Bilimsel çalışmalar

Doç. Dr. Senem Maral

152 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. PB2013 LACTATE DEHYDROGENASE LEVEL IS ASSOCIATED WITH A WORSE OUTCOME IN TURKISH PATIENTS WITH HAIRY CELL LEUKEMIA

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000566544.13472.66 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  2. A first time report on the coocurrence of sarcoidosis and ALK(−) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedotin treatment

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219837331 PMID 30909793 Kaynak: OpenAlex

  3. A rare cause of hemophagocytic lymphohistiocytosis Q fever: a case report

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30374-1 Kaynak: OpenAlex

  4. Clinical features and possible prognostic factors in patients with marginal zone lymphoma: retrospective analysis from two centers

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30277-2 Kaynak: OpenAlex

  5. A rare association, myelofibrosis secondary to essential thrombocytosis and monoclonal gammopathy of undetermined significance

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30313-3 Kaynak: OpenAlex

  6. Assessment of Clinical Course, Prognostic Features, and Treatment Response of Patients with Chronic Lymphocytic Leukemia: A Single Center Experience

    Acta Oncologica Turcica, 2019

    DOI 10.5505/aot.2019.41033 Kaynak: OpenAlex

  7. Dimethyl Sulfoxide-Induced Tonic-Clonic Seizure and Cardiac Arrest During Infusion of Autologous Peripheral Blood Stem Cells

    Cell and Tissue Banking, 2018

    DOI 10.1007/s10561-018-9718-x PMID 30099684 24 atıf (Europe PMC) Kaynak: OpenAlex

  8. Infections in patients with lymphoma: An analysis of incidence, relationship and risk factors

    The Journal of Infection in Developing Countries, 2018

    DOI 10.3855/jidc.10399 PMID 31999632 6 atıf (Europe PMC) Kaynak: OpenAlex

  9. Is antimicrobial prophylaxis necessary for lymphoma patients? A single centre, real-life experience

    Journal of Oncology Pharmacy Practice, 2018

    DOI 10.1177/1078155218795323 PMID 30134766 3 atıf (Europe PMC) Kaynak: OpenAlex

  10. Development of plasma cell leukemia in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate

    Journal of Cancer Research and Therapeutics, 2018

    DOI 10.4103/0973-1482.192762 PMID 30488870 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  11. Current Treatment Approaches to Multiple Myeloma with New Agents

    Journal of Clinical and Experimental Investigations, 2018

    DOI 10.5799/jcei.433823 Kaynak: OpenAlex

  12. The rare coexistence of high titer inhibitor development and gastrointestinal stromal tumor in a patient with severe hemophilia: A case report

    Transfusion and Apheresis Science, 2018

    DOI 10.1016/j.transci.2018.04.023 PMID 29724628 1 atıf (Europe PMC) Kaynak: OpenAlex

  13. Epidemiological and survival data of adult lymphoma patients: single centre experience

    Ortadoğu Tıp Dergisi, 2018

    DOI 10.21601/ortadogutipdergisi.395616 Kaynak: OpenAlex

  14. Acquired hemophilia with thrombosis in a cancer patient

    Blood Coagulation & Fibrinolysis, 2017

    DOI 10.1097/mbc.0000000000000670 PMID 29095762 2 atıf (Europe PMC) Kaynak: OpenAlex

  15. Rare aggressive natural killer cell leukemia presented with leukopenia and disseminated intravascular coagulation—a diagnostic challenge

    Journal of Hematopathology, 2017

    DOI 10.1007/s12308-017-0313-z Kaynak: OpenAlex

  16. Matrix Metalloproteinases 2 and 9 Polymorphism in Patients With Myeloproliferative Diseases

    Medicine, 2015

    DOI 10.1097/md.0000000000000732 PMID 25906101 12 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  17. An Independent Risk Factor For Quality of Life In Cancer Patients: Urinary Incontinence

    Acta Medica Anatolia, 2015

    DOI 10.15824/actamedica.30987 Kaynak: OpenAlex

  18. J Oncol Pharm Pract. 2019 Jul 30:1078155219863469. doi: 10.1177/1078155219863469

    Kaynak: medipol.com.tr profil sayfası

  19. 7. A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase I Clinical Study to Demonstrate Safety of Ankaferd Blood Stopper Topical Usage In Healthy Volunteers. Balcik OS, Koroglu M, Cipil H, Kaftan O, Maral S, Gurel A, Goker H, Haznedaroglu IC, Kosar A. UHOD 2012:22(4 );267-274 doi: 10.4999/uhod.10124

    Kaynak: medipol.com.tr profil sayfası

  20. 14. CD25 Expression is Associated with Autoimmunity in Patients with CLL .Ozturk Hb, Yıldız A, Albayrak M, Pala C, Maral S, Falay M . UHOD. 2019:29;123-129 doi: 10.4999/uhod.193789

    Kaynak: medipol.com.tr profil sayfası

  21. 21. A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase I Clinical Study To Demonstrate Safety of Ankaferd Blood Stopper Topical Usage In Healthy Volunteers: 336 Balcik OS, Koroglu M, Cipil H, Kaftan O, Maral S, Gurel A, Goker H, Haznedaroglu IC, Kosar A. Int J Lab Hematol 2010;32:126-127.

    Kaynak: medipol.com.tr profil sayfası

  22. 27. Modified R-IDARAM treatment in central nervous system lymphomas: A single centre experience. Maral S, Albayrak M, Pala C, Ozturk HBA, Yıldız A, Şahin O, Okutan H. Avicenna J Med. 2020: 10( 4): 227-231 DOI: 10.4103/ajm.ajm_59_19

    Kaynak: medipol.com.tr profil sayfası

  23. 28.Rare Entity in Chronic Myelocytic Leukemia: Coexistence of BCR ABL1 Translocation and JAK2 V617F Mutation. Case Report Sağlam B, Albayrak M, Yıldız A, Akyol P, Pala C,Maral S, Öztürk HBA, Tığlıoğlu M, Şahin O.SN Comprehensive Clinical Medicine (2020) 2:478–480 doi.org/10.1007/s42399-020-00252-w

    Kaynak: medipol.com.tr profil sayfası

  24. 32. Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.Gemici A, Ozkalemkas F, Dogu MH, Tekinalp A, Alacacioglu I, Guney T, Ince I, Geduk A, Cagliyan GA, Maral S, Serin I, Gunduz E, Karakus V, Bekoz HS, Eren R, Pinar IE, Gunes AK, Sargın FD, Sevindik OG. A Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):e686-e692. doi: 10.1016/j.clml.2021.04.004. Epub 2021 Apr 20.

    Kaynak: medipol.com.tr profil sayfası

  25. 39.The Importance of Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia. Öztürk HBA, Albayrak M, Yıldız A, Maral S, Akyol P, Aras MR, Falay M. UHOD , 2021:31; 199-204 doi: 10.4999/uhod.215209

    Kaynak: medipol.com.tr profil sayfası

  26. ULAKBİM ve Diğer İndekslerde Yurt içi Eserleri:

    Kaynak: medipol.com.tr profil sayfası

  27. 1.Thrombocytosis Associated with Iron Deficiency Anemia; Is It a Masked Myeloproliferative Disorder? Maral S. AMJ 2019:19(2);375 – 380 DOI: 10.17098/amj.570912

    Kaynak: medipol.com.tr profil sayfası

  28. 3. Erişkin lenfoma hastalarının epidemiyolojik ve sağkalım verileri: tek merkez deneyimi. Yıldız A , Afacan Öztürk H , Albayrak M , Şahin O , Pala Öztürk Ç , Maral S , Sarıbacak Can E , Güneş G , Okutan H . Ortadoğu Tıp Dergisi. 2018; 240-246. doi.org/10.21601/ortadogutipdergisi.395616

    Kaynak: medipol.com.tr profil sayfası

  29. 6. Kronik Lenfositik Lösemi Tanılı Olguların Klinik Seyir, Prognostik Özellikler ve Tedavi Cevabı Yönünden Değerlendirilmesi: Tek Merkez Deneyimi Öztürk HBA, Albayrak M, Pala C, Maral S, Yıldız A, Şahin O, Cömert P. Acta Oncol Tur.. 2019; 52(3): 383-387 | DOI: 10.5505/aot.2019.41033

    Kaynak: medipol.com.tr profil sayfası

  30. Yurt İçi ve Yurt Dışı Poster ve Sözlü Sunumlar

    Kaynak: medipol.com.tr profil sayfası

  31. 1. A Case Of Transfusion Related Acute Lung Injury (TRALI)

    Kaynak: medipol.com.tr profil sayfası

  32. Maral S, Bakanay SM, Izdes S, Dilek I XII. Asian Assosiation of Transfusion medicine congress, IX. National transfusion medicine Congress (2016) REF NO:101 Oral Presentation-8

    Kaynak: medipol.com.tr profil sayfası

  33. 2. Bleomycin-induced pulmonary fibrosıs: experience of two cases in a single centre. S. Maral, M. Albayrak, A. Yıldız, O. Şahin, Ç. Özturk, Ü. Malkan, G. Guneş, E. Sarıbacak Can. VIII. International Eurasian Hematology Congress / Leukemia Research 61S1 (2017),Oral presentation -32

    Kaynak: medipol.com.tr profil sayfası

  34. 3.A case with multiple solitary plasmacytomas secreting monoclonal protein. Senem maral, Sule Mine Bakanay Aysun Senturk Yıkılmaz İmdat Dilek Internetional leukemia lymphome myeloma congres 2017 refno:65

    Kaynak: medipol.com.tr profil sayfası

  35. 4.Does Ferritin and vitamin b12 levels have prognostik sigfiance in multiple myeloma patients?Sema akıncı,Aysun Senturk Yıkılmaz,Kamile Sılay,Senem maral ,sule mine bakanay,selin küçükyurt kaya,imdat dile Dilek Internetional leukemia lymphome myeloma congres 2017 ref no:17 ps-08

    Kaynak: medipol.com.tr profil sayfası

  36. 5.Multiple myeloma in Patients older Than 65 years:a comparative study with younger adult multiple myeloma patients. Sema akıncı,Aysun Senturk Yıkılmaz,Kamile Sılay,Senem maral ,sule mine bakanay,selin küçükyurt kaya,Muhammet Bülent akıncı.imdat dilek Dilek Internetional leukemia lymphome myeloma congres 2017 ref no:14 ps-14

    Kaynak: medipol.com.tr profil sayfası

  37. 6.The effect of gender on bone lesions in multiple myeloma patients. Aysun Senturk Yıkılmaz,Kamile Sılay,Senem maral ,sule mine bakanay,selin küçükyurt kaya,imdat dile Dilek Internetional leukemia lymphome myeloma congres 2017ref no:65

    Kaynak: medipol.com.tr profil sayfası

  38. 7. Importance of screening accessory spleen in refractory immune thrombocytopenia. O. Şahin, M. Albayrak, A. Yıldız, S. Maral, C. Pala Ozturk, H. Afacan Ozturk, U. Malkan, G. Guneş, E. Sarıbacak Can. VIII. International Eurasian Hematology Congress / Leukemia Research 61S1 (2017), PP-40

    Kaynak: medipol.com.tr profil sayfası

  39. 8. Modıfıed r-idaram treatment in central nervous system lymphomas: A single centre experience. S. maral, M. albayrak, C. Pala, H.B. Afacan Ozturk, A. Yıldız, O. Şahin, H. Okutan. 23rd EHA congress, Stockholm, Sweden 2018; 2(s1) 821 (PB1797)

    Kaynak: medipol.com.tr profil sayfası

  40. 9.Management of adult immune thrombocytopenia: single-center experience of 9 years. O. Şahin, A. Yıldız, M. Albayrak, C. Pala Ozturk, H. Afacan Ozturk, P. Comert, S. Maral. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S26, Oral Presentation-19

    Kaynak: medipol.com.tr profil sayfası

  41. 10.A first-time report on the co-occurrence of sarcoidosis and ALK(-) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedontin treatment. H. Afacan Ozturk, M. Albayrak, C. Pala Ozturk, A. Yıldız, S. Maral, E. Onder. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S27, OralPresentation-22

    Kaynak: medipol.com.tr profil sayfası

  42. 11. An unusual coexistence of high titer inhibitor development and gastrointestinal stromal tumor in a patient with severe hemophilia: Case report' Abdulkerim Yıldız, Osman Şahin, Okan Yayar, Çiğdem Pala Öztürk, Hacer Berna Afacan Öztürk, Senem Maral, Harika Okutan, Murat Albayrak. 11th Annual Congress of the European Association for Haemophilia and Allied Disorders, Madrid, Spain, 2018. P-169

    Kaynak: medipol.com.tr profil sayfası

  43. 14. A rare presentation of recurrence in acute lymphoblastic leukemia: isolated optic nerve involvement. P. Comert, M. Albayrak, A. Yıldız, C. Pala Ozturk, S. Maral, H. Afacan Ozturk, O. Şahin, B. Sağlam. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S36, PP-07

    Kaynak: medipol.com.tr profil sayfası

  44. 15. Intermittent bevacizumab therapy experience in hereditary hemorrhagic telangiectasia. O. Sahin, M. Albayrak, A. Yıldız, P. Comert, C. Ozturk, S. Maral, H. Afacan Ozturk. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S39, PP-14

    Kaynak: medipol.com.tr profil sayfası

  45. 16. An unexpected complication: transverse myelitis after autologous stem cell transplantation. P. Comert, M. Albayrak, A. Yıldız, O. Şahin, C. Pala Ozturk, S. Maral, G. Guneş, H. Afacan Ozturk, B. Sağlam. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S43, PP-26

    Kaynak: medipol.com.tr profil sayfası

  46. 18. Lactate Dehydrogenase Level Is Associated With A Worse Outcome In Patients With Hairy Cell Leukemia. Senem Maral, Murat Albayrak, Simten Dagdas, Abdulkerim Yıldız, Rahsan Yıldırım, Merih Oz, Cigdem Pala, Berna Ozturk, Ilker Bay, Gulsum Ozet, Imdat Dilek.24th EHA congress, Amsterdam.2019; (PB2013)

    Kaynak: medipol.com.tr profil sayfası

  47. 20. Monoklonal Gamopati ilişkili kriyoglobunemi. Maral S. 28-29 Kasım 2020 7.Akdeniz Sempozyumu (online toplantı) Sözlu sunum

    Kaynak: medipol.com.tr profil sayfası

  48. 21. HKNH de Aşılama. Maral S. 01-03 Ekim 2020 5.Ulusal Kan ve Kemik İliği Kongresi (online toplantı) Sözlu Sunum

    Kaynak: medipol.com.tr profil sayfası

  49. 22. Yenı̇ Tanı Multı̇ple Myelom Hastalarında Kemı̇k İlı̇ğı̇ Fı̇brozı̇sı̇nı̇n Prognoz Ve Yanıt Üzerı̇ne Etkı̇sı̇ Var Mıdır? Maral S, Karakus V, Albayrak M, Sevindik OG46. Ulusal Hematoloji Kongresi 2020 (Online toplantı) Sözel sunu-35 Referans Numarası: 116

    Kaynak: medipol.com.tr profil sayfası

  50. 23. Yenı̇ Tanı Yaşlı Aml Hastalarında Azacı̇tı̇dı̇n Ve Decı̇tabı̇ne İdamesı̇nı̇n Tedavı̇ye Katkısı: Gerçek Yaşam Verı̇sı̇. Karakuş V, Kaya K, Maral S, Gemici AI , Dere Y, Albayrak M, Sevindik OG 46. Ulusal Hematoloji Kongresi 2020 (Online toplantı) Sözel sunu -09 Referans Numarası: 3

    Kaynak: medipol.com.tr profil sayfası